FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileSTERIS plc
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
STE
STERIS plc Stock AnalysisComprehensive stock analysis for STERIS plc (STE) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSTE
STE
STERIS plc
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
STE
  1. Home
  2. Stocks
  3. STERIS plc

STERIS plc

🇺🇸STE•NYSE

STERIS plc

🇺🇸STE•NYSE
Market cap
$25.43B
Sentiment

Your view on STE

Mkt Cap
$25.43B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About STERIS plc

Industry
Medical - Specialties
Sector
Healthcare
CEO
Daniel A. Carestio
Headquarters
70 Sir John Rogerson's Quay, Dublin, IE
Industry
Medical - Specialties
Sector
Healthcare
CEO
Daniel A. Carestio
Headquarters
70 Sir John Rogerson's Quay, Dublin, IE
Description

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental.

The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services.

The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities.

The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors.

This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite.

The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for STERIS plc from FRC's valuation model, read against the market price. STE last traded at $261.91, 31.0× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for STERIS plc. Starting points for STERIS plc: P/E 31.0, EPS $8.50, beta 0.86 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for STERIS plc. STERIS plc paid $2.58 per share over the last year — a 1.0% yield at the current $261.91 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for STERIS plc. Trailing twelve-month EPS for STERIS plc stands at $8.50. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$279.75

average of 4 firms, last 12 months

 

$279.75

Low $269.00

Median $272.50

High $305.00

 

Analyst Ratings

Buy3 firms, last 12 months
  • Strong Buy0
  • Buy3
  • Hold0
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Mar 2027Next YearFY Mar 2028
Avg. estimate$2.79$3.14$11.45$12.44
Low estimate$2.77$3.11$11.25$12.28
High estimate$2.84$3.17$11.66$12.68
No. of analysts4455
Year-ago EPS$2.53$2.83$7.93—
Growth+10.3%+11.0%+44.4%—

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Mar 2027Next YearFY Mar 2028
Avg. estimate$1.60B$1.71B$6.39B$6.82B
Low estimate$1.59B$1.70B$6.38B$6.75B
High estimate$1.62B$1.73B$6.42B$6.98B
No. of analysts4466
Year-ago revenue$1.50B$1.59B$5.94B—
Growth+7.0%+7.4%+7.6%—
Recent analyst actions15 rating and price-target changes, latest Nov 13, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for STERIS plc. STERIS plc has reported as a listed company since 1992. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold STE17 companies · 8 funds
Compare STE with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • CNVVFConvaTec Group PlcMedical - Instruments & Supplies$7.1B
  • GNGBYGetinge AB (publ)Medical - Devices$6.1B
  • MLABMesa Laboratories, Inc.Medical - Specialties$754M
  • SDMHFSartorius Stedim Biotech S.A.Medical - Instruments & Supplies$21.2B
  • SHCSotera Health CompanyMedical - Diagnostics & Research$4.6B

More Medical - Specialties companies

  • WOKWORK Medical Technology Group Ltd.NASDAQ$5M
  • YPHDFYpsomed Holding AGOTC$5.2B
  • ACAISafeplus International Holdings LimitedOTC$477
  • ADLIAmerican Medical Technologies Inc.OTC$1,031
  • AIMVAI Maverick Intel, Inc.OTC$3M
  • ALCAlcon Inc.NYSE$35.4B
  • ANIKAnika Therapeutics, Inc.NASDAQ$173M
  • APYXApyx Medical CorporationNASDAQ$112M
  • ASFXAmerican Scientific Resources, IncorporatedOTC$7,001
  • AVTIAvitar, Inc.OTC$1,382
  • BEATHeartBeam, Inc.NASDAQ$20M
  • BEATWHeartBeam, Inc.NASDAQ$7M

ETFs holding STERIS plc

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.03%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.03%
  • VOVanguard Mid-Cap ETF$103.4B in assets0.21%
  • IVViShares Core SP 500 ETF$852.9B in assets0.04%
  • IHIiShares US Medical Devices ETF$4.0B in assets3.18%
  • CSMDCongress SMID Growth ETF$481M in assets2.67%
  • NUMVNuveen ESG Mid-Cap Value$427M in assets1.82%
  • FXHFirst Trust Health Care AlphaDEX Fund$1.2B in assets1.58%

Largest holders first, then the funds most concentrated in STE.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold STERIS plc, and how their positions are changing. At a $25.43B market value, institutional positions materially move STERIS plc's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by STERIS plc executives and directors. Shares of STERIS plc have traded between $200.98 and $268.30 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming STERIS plc. STERIS plc is a $25.43B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming STERIS plc. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for STERIS plc. Coverage tracks STERIS plc within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of STERIS plc.

STE Analysis
Fair
Past2
Growth4
Health4
Profit3
Value1

News

Latest Market News